Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05307874
Title Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors (EVICTION-2)
Acronym EVICTION-2
Recruitment Recruiting
Gender
Phase Phase Ib/II
Variant Requirements No
Sponsors ImCheck Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.